SenthilNSundaramMDMPH
Cardiology • Raleigh, NCAdult Congenital Heart Disease, Echocardiography
Physician
Dr. Sundaram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3000 New Bern Ave
Ste 1200
Raleigh, NC 27610Phone+1 919-231-6132Fax+1 919-231-6276
Education & Training
Temple University HospitalFellowship, Cardiovascular Disease, 1999 - 2002
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Gastroenterology, 1995 - 1996
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1993 - 1995
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1992 - 1993
Madurai Medical CollegeClass of 1990
Certifications & Licensure
FL State Medical License 2009 - 2027
GA State Medical License 2010 - 2026
MO State Medical License 2010 - 2026
UT State Medical License 2010 - 2026
VA State Medical License 2002 - 2026
AL State Medical License 2022 - 2025
CO State Medical License 2011 - 2025- American Board of Internal Medicine Cardiovascular Disease
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 7 citationsRecurrent cerebral abscess secondary to a persistent left superior vena cava.Jonathan N. Menachem, Senthil N. Sundaram, John F. Rhodes
Congenital Heart Disease. 2014-05-01 - 2 citationsMyocardial perfusion and function: single photon emission computed tomography.Christopher L Hansen, Richard A Goldstein, Olakunle O Akinboboye, Daniel S Berman, Elias H Botvinick
Journal of Nuclear Cardiology. 2007-11-21
Press Mentions
Terns Appoints Veteran Biopharmaceutical Executive Ann E. Taylor, M.D. To Board of DirectorsSeptember 28th, 2021- Terns Pharmaceuticals : Reports Second Quarter 2021 Financial Results and Corporate Highlights (Form 8-K)August 18th, 2021
- Terns Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate HighlightsAugust 16th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
